Stockholders’ Equity (Details) - USD ($)		3 Months Ended				9 Months Ended		12 Months Ended
	Aug. 01, 2022	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Stockholders’ Equity (Details) [Line Items]
Restricted shares value (in Dollars)		$ 0				$ 0
Subscription payable, description						As a result, the company received $13,000 in cash proceeds as part of the transaction.During the nine months ended September 30, 2022, the company issued 25,000 shares of common stock upon result of the two warrant exercises of 12,500 shares each, or 25,000 shares of common stock in the aggregate, at an exercise price of $0.05 a share.
Cash proceeds (in Dollars)						$ 1,250
Shares granted (in Dollars per share)	$ 1,000,000
Exercise price (in Dollars per share)	$ 2.36
Restricted shares						400,000
Forfeited shares						950,000
Compensation expense (in Dollars)						$ 176,000
Sale of current liability (in Dollars)		585,000				585,000
Cash proceeds (in Dollars)						585,000
Recognized stock based compensation expense (in Dollars)		$ 1,261,626	$ 848,277			$ 1,261,626	$ 848,277
Series A convertible preferred stock, issued		13,602				13,602		13,602
Accrued dividends (in Dollars)						$ 314,546
Series A convertible preferred stock, liquidation preference (in Dollars per share)		$ 25				$ 25
Series A convertible preferred stock, dividend rate						6.50%
Weighted average of the last sales prices						95.00%
Dividend rate increase						10.00%
Preferred stock conversion price per share (in Dollars per share)						$ 12
Stockholders equity, description						If the closing sale price of the common stock is greater than 140% of the conversion price on 20 out of 30 trading days, the company may redeem the Series A Preferred Stock in whole or in part at any time through October 31, 2010, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the shares to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, subject to certain conditions. In addition, beginning November 1, 2010, the company may redeem the Series A Preferred Stock in whole or in part, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the Series A Preferred Stock to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, under certain conditions.
Common stock discount shares description						The purchase price is payable, at the corporation’s option, (x) in cash, (y) in shares of the common stock at a discount of 5% from the fair market value of Common Stock on the Purchase Date (i.e. valued at a 95% discount of the Common Stock on the Purchase Date), or (z) any combination thereof.
Preferred stock, annual dividend (in Dollars)						$ 34,000	34,000
Reserved a total possible issuance under the plan						50,000,000
Total stock-based compensation expense for grants (in Dollars)						$ 1,261,626	848,277
Share based compensation of restricted stock agreement shares								140,000
Restricted stock awards value (in Dollars)							84,000
Recognized restricted stock awards value (in Dollars)						$ 580,000	$ 84,000
Restricted stock, grants description						The shares vest annually over two years with the first installment one year from the agreement; provided, however, if either party terminates the agreement at any time prior to the last date of it ending, then the shares will vest, pro rata, for each month served since the most recent prior annual vesting date.
Shares issued		250,000				250,000
Restricted stock amount (in Dollars)						$ 42,297
Shares vest portably years						4 years
Percentage of vested						25.00%
Remaining expensed percentage						50.00%
Remaining expensed period						3 years
Stock based compensation description						The $1,261,626 stock-based compensation for the nine months ended September 30, 2022, was comprised of $930,077 option expense, $108,549 expense from the vesting of the restricted stock and $223,000 was the amortization of 5,000,000 shares of stock valued at $0.4014 over three years for the acquisition of assets of Applied Optical Sciences.
Unrecognized stock based compensation (in Dollars)						$ 4,998,280
Stock based compensation restricted stock agreements (in Dollars)		$ 1,414,923				$ 1,414,923		$ 15,355
Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares		25,000	600,000	450,010	600,000		158,329
Shares issued for convertible notes							47,499
Warrant [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares							800,000
Stock value issued for exercise of warrants			800,000				800,000
Warrant exercise price per share (in Dollars per share)			$ 0.07				$ 0.07
Warrant One [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares							250,000
Stock value issued for exercise of warrants			250,000				250,000
Warrant exercise price per share (in Dollars per share)			$ 0.06				$ 0.06
Options [Member]
Stockholders’ Equity (Details) [Line Items]
Warrant exercise price per share (in Dollars per share)			$ 0.37				$ 0.37
Common stock option exercise			259,741				259,741
Stock option exercise price Per share (in Dollars per share)							$ 500,000
Restricted Stock Agreement [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares						130,417
Warrant exercise price per share (in Dollars per share)			$ 0.4				$ 0.4
Common stock option exercise			1,760,000				1,760,000
Options vest over a period						3 years
Warrant Two [Member]
Stockholders’ Equity (Details) [Line Items]
Stock value issued for exercise of warrants			50,000				50,000
Warrant exercise price per share (in Dollars per share)			$ 0.06				$ 0.06
Common stock option exercise			50,000				50,000
Warrant Three [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares							100,000
Stock value issued for exercise of warrants			100,000				100,000
Warrant exercise price per share (in Dollars per share)			$ 0.07				$ 0.07
Warrant Four [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares							200,000
Stock value issued for exercise of warrants			200,000				200,000
Warrant exercise price per share (in Dollars per share)			$ 0.06				$ 0.06
Warrant Five [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares							125,000
Stock value issued for exercise of warrants			125,000				125,000
Warrant exercise price per share (in Dollars per share)			$ 0.06				$ 0.06
Options Two [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares						100,000
Net cash proceeds (in Dollars)						$ 13,000
Common stock option exercise		100,000	500,000			100,000	500,000
Stock option exercise price Per share (in Dollars per share)						$ 0.13
Common stock withheld with exercise			25,000				25,000
Preferred Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Liquidation preference						101.00%
Minimum [Member]
Stockholders’ Equity (Details) [Line Items]
Liquidation preference						1.00%
Vested Period						1 year
Maximum [Member]
Stockholders’ Equity (Details) [Line Items]
Liquidation preference						6.50%
Vested Period						2 years
Warrant Six [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares							60,000
Stock value issued for exercise of warrants			60,000				60,000
Warrant exercise price per share (in Dollars per share)			$ 0.06				$ 0.06
Warrant Seven [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares							65,000
Stock value issued for exercise of warrants			65,000				65,000
Warrant exercise price per share (in Dollars per share)			$ 0.06				$ 0.06
Options Two [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares							475,000
Options Three [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares							482,143
Common stock option exercise			500,000				500,000
Common stock withheld with exercise			17,857				17,857
Private Placement [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares							7,056,250
Price per share (in Dollars per share)							$ 0.32
Net cash proceeds (in Dollars)							$ 2,258,000
Private Placement One [Member]
Stockholders’ Equity (Details) [Line Items]
Net cash proceeds (in Dollars)							$ 3,041,000
Warrant exercise price per share (in Dollars per share)			$ 0.75				$ 0.75
Common stock option exercise			4,054,665				4,054,665
Series A Preferred Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Series A convertible preferred stock, issued		13,602				13,602		13,602
Liquidation preference						7.50%
Business Combination [Member]
Stockholders’ Equity (Details) [Line Items]
Issuable in acquisition, description						As of September 30, 2022 and December 31, 2021, the company in aggregate recorded $1,561,000 and $1,338,000, respectively, in stock-based compensation related to a lockup agreement on 5,000,000 shares of common stock in the acquisition of assets of AOS valued at $0.4014 per share, representing the closing price on the date of the contract which is amortized over 36 months, of which, $223,000 and $501,750, respectively, was amortized for the nine months ended September 30, 2022, and 2021.
Chief Financial Officer [Member]
Stockholders’ Equity (Details) [Line Items]
Shares issued		400,000				400,000
Restricted Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares							31,250
Stock value issued for restricted stock agreement (in Dollars)							$ 4,550
Recognized restricted stock awards value (in Dollars)						$ 928,000
Restricted stock amount (in Dollars)						50,780
Statements of operations [Member]
Stockholders’ Equity (Details) [Line Items]
Preferred stock, annual dividend (in Dollars)						$ 25,004	$ 25,504